NCT02708992View on ClinicalTrials.gov

Cefixime / Azithromycin pK Study

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

July 31, 2017

Conditions
Gonorrhoea
Interventions
DRUG

Azithromycin

DRUG

Cefixime

Trial Locations (1)

27710-4000

Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02708992 - Cefixime / Azithromycin pK Study | Biotech Hunter | Biotech Hunter